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Ion channel recordings on an injection-molded
polymer chip†
Simone Tanzi,a Marco Matteucci,a Thomas Lehrmann Christiansen,a Søren Friis,b
Mette Thylstrup Christensen,b Joergen Garnaes,c Sandra Wilson,b
Jonatan Kutchinskyb and Rafael Taboryski*a
In this paper, we demonstrate recordings of the ion channel activity across the cell membrane in a biological cell
by employing the so-called patch clamping technique on an injection-molded polymer microfluidic device. The find-
ings will allow direct recordings of ion channel activity to be made using the cheapest materials and production
platform to date and with the potential for very high throughput. The employment of cornered apertures for cell
capture allowed the fabrication of devices without through holes and via a scheme comprising master origination
by dry etching in a silicon substrate, electroplating in nickel and injection molding of the final part. The most critical
device parameters were identified as the length of the patching capillary and the very low surface roughness on
the inside of the capillary. The cross-sectional shape of the orifice was found to be less critical, as both rectangular
and semicircular profiles seemed to have almost the same ability to form tight seals with cells with negligible leak
currents. The devices were functionally tested using human embryonic kidney cells expressing voltage-gated
sodium channels (Nav1.7) and benchmarked against a commercial state-of-the-art system for automated ion chan-
nel recordings. These experiments considered current–voltage (IV) relationships for activation and inactivation of
the Nav1.7 channels and their sensitivity to a local anesthetic, lidocaine. Both IVs and lidocaine dose–response
curves obtained from the injection-molded polymer device were in good agreement with data obtained from the
commercial system.
Introduction
The patch clamping technique was introduced in 1976 by
Neher and Sakmann1 and has become the accepted stan-
dard for fundamental studies of ion channel proteins and
the discovery of drugs that affect them. Ion channels play a
central role in the excitability of nerves and muscles; they
underlie the heartbeat, muscle contractions and brain activ-
ity as well as many other basic physiological actions.2 Ion
channels are macromolecular pores with the ability to regu-
late the movement of ions across the otherwise
impermeable cell membrane.2 Ion channels are also
involved in a diverse range of disorders and pathological
conditions, called channelopathies.3,4 Mutations in ion
channel genes have been associated with diseases such as
cystic fibrosis, hypertension, ataxia, arrhythmia and several
types of epilepsy.4,5 In pharmacology, ion channels repre-
sent highly attractive targets for drug discovery with an esti-
mated market of US $12 billion.6,7
Despite their enormous potential as druggable targets, the
use of ion channels for drug discovery has been well behind
the expectation, mainly due to the lack of adequate screening
technology.8 Conventional manual patch clamping delivers
high information content, but it is a complex technique that
requires skilled personnel and suffers from extremely low
throughput, while, on the other hand, all indirect screening
methods suffer from low specificity and, thus, the associated
risk of generating false negative or positive results.8,9 With
the promise of removing this trade-off, the first automated
parallel patch clamping system (APC) was made available in
2003.10 Since then, 5 companies (Molecular Devices, Sophion
Bioscience, Nanion, Cytocentric, and Fluxion) have entered
the market, establishing APC as an essential technology for
secondary screening, lead optimization and cardiac safety
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testing.11 Performances of the different systems have been
discussed in a few reviews.11–14 APC systems replace the use
of conventional glass micropipettes with single-use, dispos-
able devices fabricated using materials such as quartz15 and
silicon/silicon dioxide.16 The majority of the available plat-
forms share the so-called planar approach, where cells in
suspension are blindly positioned by suction onto micro-
apertures made as through holes in thin membranes.15
Alternatively, a lateral approach has been proposed, where
suspended cells are trapped at lateral apertures generated at
the junction of two microfluidic channels.17
The ability to form a high electrical resistance seal, pref-
erably in the order of GΩ (the so-called gigaseal) between
the aperture and the biological cell membrane, and the fab-
rication of such micro-sized through holes in thin sub-
strates (10–20 μm) are the two most relevant benchmarks.
These constraints have traditionally narrowed the range of
usable materials and technologies to almost exclusively
micromachining of silicon and glass, at least for commer-
cial use.
The use of polymeric substrates has also been widely investi-
gated, and planar microfluidic chips have been demonstrated
in hybrid polydimethylsiloxane–polyimide (PDMS–PI),18
polyimide,19 oxygen plasma-treated PDMS20,21 and polyethylene
glycol (PEG)–SU-8 mixture.22 Unfortunately, all the aforemen-
tioned polymer devices have so far failed to deliver relevant
electrophysiological results. It has been more or less implicitly
believed in the community that silicon oxide surfaces possess a
unique surface chemistry for forming gigaseals, essentially
through van der Waals interactions.23–25 The interaction
between lipid membranes and other surfaces is, however, com-
plicated and only poorly understood and, thus, leaves some
leverage for challenging the uniqueness of these surfaces26–30
by employing polymers. Ionescu-Zanetti et al. implemented lat-
eral junctions in a microfluidic device fabricated by casting of
polydimethylsiloxane (PDMS).17,31 In 2009, this device was even-
tually commercialized by Fluxion, and it remains the only APC
system relying on cornered apertures to date.32
Looking at all of the commercially available APC systems,
the manufacturing cost per device is still prohibitive for
establishing APC as a routine technique.33 Of the two mate-
rials employed nowadays, silicon remains extremely costly to
purchase and machine, while PDMS is less suitable for mass
production. Moreover, PDMS has issues when used for bio-
logical applications such as high permeability for small mole-
cules, non-cross-linked oligomers, and surface diffusion of
low molecular weight chains.34
The aim of this work is to propose a method for massive
production of extremely cheap APC systems without
compromising functionality. The trick lies in understanding
the requirements to form tight seals between thermoplastic
polymers and the cells. By shaping apertures that allow for a
considerably larger effective interface area between low-
energy polymer surfaces and the cell membrane, we demon-
strate the formation of gigaseals, enabling high-quality ion
channel recordings. The proposed device consists of only two
parts: an injection-molded part in TOPAS cyclic olefin copoly-
mer (COC) comprising the microfluidics and a polymer film
of the same polymer grade, which is thermally bonded to the
injection-molded part.35 For comparison, the commercially
available QPlate™ from Sophion Bioscience comprises several
materials, thermoplastic polymer, elastomer, ceramic, glass,
and silicon. Moreover, TOPAS has none of the previously
mentioned limitations of PDMS. Furthermore, the materials
and fabrication platform fulfills all the requirements for
cheap manufacturing in terms of “design for manufacturabil-
ity”, “economy of scale” and production yield, and it avoids
all drawbacks typical of prototyping methods.36 After an ini-
tial investment in master mold origination, injection molding
delivers a cost per part that exponentially decreases with the
number of parts, becoming the cheapest technology when
production is greater than ~10 000 units.36 After assembly
into chips, the systems were tested with HEK cells expressing
Nav1.7, a voltage-gated sodium channel appropriate for
benchmarking studies. Experiments were designed to explore
current–voltage (IV) relationships for activation and inactiva-
tion of Nav1.7 channels and their sensitivity to a local anes-
thetic, lidocaine. Both IVs and lidocaine dose–response
curves obtained from the injection-molded polymer device
were benchmarked against the commercially available
QPatch™ system from Sophion Bioscience. In the following
section, we provide the details of the device layout and func-
tionality, benchmarking tests against existing state-of-the-art
methods, and finally a surface topology characterization of
the patching capillaries.
Materials and methods
Device fabrication
Chips were manufactured according to the methods recently
reported by some of the same authors,37 which in brief con-
sist of lithography, dry etching of the silicon, electroplating
in nickel and injection molding of the polymer parts. Two
etching processes were employed to form the patching capil-
laries: Bosch reactive ion etching for sample A and continu-
ous reactive ion etching for sample B. This was to obtain,
respectively, rectangular and semicircular profiles. However,
in order to replicate patch clamping orifices smaller than the
lateral apertures demonstrated for cell trapping,37 the overall
process was partially modified. Silicon oxide used as masking
material was replaced by standard photoresist, while a thin
layer of oxide was applied after the first etching step to pre-
vent damage to the patching channels during the rest of the
process. Fabrication was then completed by alternating wet
etching steps and oxidation in order to smooth the surfaces
around the patching orifices. Details of the full process are
given in the ESI.† Parts were molded from COC (TOPAS 5013,
Advanced Polymers GmbH). A 100 μm thick extruded poly-
mer film (TOPAS 5013F-04, Advanced Polymers Extrusion
Lab) was used as a cover lid. The two parts were bonded by
UV-assisted thermal bonding.35
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Cell culture
Human embryonic kidney 293 cells (HEK 293) expressing
the subtype of the voltage-gated sodium channel Nav1.7
were provided by Scottish Biomedical Ltd. The cells were
grown and maintained under standard culture conditions at
37 °C and 5% CO2. The cells were cultured in T175 culture
flasks (Nunc A/S) to a maximum 80% confluence in high-
glucose Dulbecco's modified Eagle's medium (DMEM,
Sigma-Aldrich D0819) supplemented with 10% fetal bovine
serum (FBS, Sigma-Aldrich F2442), 2 μg ml−1 blasticidin S
(Sigma-Aldrich 15205) and 600 μg ml−1 geneticin (Sigma-
Aldrich G8168). The cells were sub-cultured for two weeks
before reaching a stable growth pattern and then used in
the experiments. For sub-culture, the culture medium was
removed and the cells were washed with phosphate-buffered
saline (PBS) without calcium chloride and magnesium chlo-
ride (Sigma-Aldrich D8537). Trypsin/EDTA (Sigma-Aldrich
T4174) was added to the culture flask, and the flask was
incubated at 37 °C for 2 minutes. The medium was added
to the flask, and the cells were re-suspended and placed in
a new mother flask. Directly before experiments, the culture
medium was removed and the cells were washed with
PBS without calcium chloride and magnesium chloride.
Detachin (VWR) was added to the culture flask, and the
flask was incubated at 37 °C for 5 minutes or until the cells
showed a round shape indicating detachment from the flask
surfaces. The cells were re-suspended in serum-free CHO
medium (Sigma-Aldrich C5467) supplemented with 25 mM
HEPES (Sigma-Aldrich H0887), 100 μg ml−1 penicillin/strep-
tomycin (Sigma-Aldrich P4333) and 0.04 mg ml−1 soybean
trypsin inhibitor (Sigma-Aldrich T6522). Cell density and via-
bility were determined by diluting an aliquot 1 : 2 in Trypan
blue (Sigma-Aldrich T8154) and performing a cell count
using the dye exclusion method in a hemocytometer. Cell
concentration in the suspension was 2–3 M ml−1.
Solutions and compounds
The intracellular electrolyte solution contained (in mM):
135 CsF, 1/5 ethylene glycol tetraacetic acid (EGTA)/CsOH,
10 mM HEPES and 10 NaCl. The pH was adjusted to 7.3 with
KOH and osmolarity to 320 mOsm with sucrose. The extracel-
lular electrolyte solution contained (in mM): 1 CaCl2, 1 MgCl2,
5 HEPES, 3 KCl, 140 NaCl, 0.1 CdCl2 and 20 TEA–Cl. The pH
was adjusted to 7.3 with NaOH and osmolarity to 320 mOsm
with sucrose. All chemicals were purchased from Sigma-
Aldrich. Both solutions were stored in a fridge at 4 °C and
vacuum degassed for 20 minutes before use. Lidocaine hydro-
chloride monohydrate (Sigma-Aldrich L5647) was dissolved
in dimethyl sulfoxide (DMSO) to give a 100 mM stock solu-
tion kept in the freezer. Subsequent dilutions were performed
in an extracellular electrolyte solution.
Instrumentation
Recordings were carried out using a HEKA Patch Clamp EPC
9 amplifier (HEKA Electronics) at room temperature. Pulse
software (v 8.53, HEKA Electronics) was used for data acquisi-
tion. The device was mounted into a customized aluminum
box and positioned on the stage of an Olympus IX70 inverted
microscope. The two inlet ports connected to the recording
patching channel were connected to two reservoirs filled
with electrolyte solution and from them to a custom-made
pressure controller and controlled with Labview software
(National Instruments). Electrodes were electrically connected
to the EPC9 head stage mounted on the customized alu-
minum box, and the chip resistance could be monitored by
applying a 10 mV test square pulse for 10 ms. Before cell
trapping, a positive pressure of 3–5 mbar was applied to the
patching channel to prevent aperture contamination. A cell
was captured at the hole after applying suction (negative
pressure of 400 mbar) to the patching channel. The amplifier
offset potential was zeroed prior to patching the cell, and the
holding potential was held at −90 mV. Response currents
were sampled at 10 kHz and filtered at 2.9 kHz with a 4-pole
Bessel filter. The experiments on the QPatch™ were set up
using standard assay settings. In brief, cells were positioned
with a negative pressure of −100 mbar until a gigaseal was
formed. The cell membrane was then ruptured with a nega-
tive pressure pulse of −250 mbar in order to get electrical
access to the cell membrane. During this process, the offset
potential, the chip capacitance and the cell capacitance were
canceled out. The actual experiment protocol with the
relevant voltage protocols and compound additions was
programmed in the Sophion Assay Software, and it was exe-
cuted after whole-cell formation was established. QPatch™
data were sampled at 10 kHz and filtered with an 8-pole
Bessel filter at 3 kHz.
Whole-cell recordings
Once the cells were trapped, a suction of −400 mbar was
applied for about 20 seconds and then reduced to −30 mbar.
The resistance across the aperture was continuously monitored
by applying a 10 mV pulse for 10 ms. At this stage, the resis-
tance was typically between 100 and 200 MΩ. Some of the cells
showed whole-cell configuration immediately after patching.
Otherwise, the whole-cell configuration was achieved by apply-
ing combined suction pulses (from −30 mbar to −400 mbar)
and electrical pulses. Achievement of whole-cell configuration
was verified by depolarizing the cell. Eventually, the cells
reached whole-cell configuration and the resistance gradually
increased over minutes during the experiments.
Voltage protocols
For IV relationship experiments, a protocol with incremen-
tal steps of +10 mV from −90 mV to +70 mV of 1000 ms
duration was used. Steady-state inactivation was investi-
gated at +10 mV for 100 ms after the 1000 ms pre-pulse.
Each incremental sweep took place with 5 second intervals.
For concentration–response experiments, two consecutive
depolarizations to +0 mV, respectively of 100 ms and 20 ms
duration from a holding potential of −100 mV were used.
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The two depolarizations were spaced out by 15 ms at the
holding potential.
Results and discussion
The chip design contains four independent lateral apertures
600 μm apart, which are aligned along a straight channel
reserved for extracellular electrolyte solution, as shown in
Fig. 1a–c. The side channels are connected at the other end
to four separate inlet channels which contain intracellular
electrolyte solution. The patching channel is Y shaped and
consists of a straight capillary with a rectangular profile and
rounded corners (approximately 2 μm × 2 μm) at the end
where the cell is captured and a wider opening at the
opposing end for the reduction of the total hydraulic resis-
tance. In addition, a second type of device with a semicircu-
lar profile was molded and tested. The two groups of devices
will be called type A (rectangular profile) and type B (semicir-
cular profile). A cell trapped at one of the patching orifices is
shown in Fig. 1d. It was observed that the cell membrane
tends to protrude a long distance into the patching capillary,
as also previously reported for PDMS devices.17,38 In order to
find the optimal length of the patching channels, we made
all four channels with different lengths. The optimal length
of the straight capillary fraction appeared to be the largest we
had (45 μm), while shorter capillaries did not show good
sealing properties. This indicates that the gigaseal formation
must occur due to interaction between the cell membrane
Fig. 1 (a) Layout of the microfluidic device. (b) Close-up of the key part of the design with patching channel, channel for compound perfusion and channel for cell loading.
(c) SEM micrograph of the Y-shaped patching channel connecting extra- and intracellular channels. (d) Optical microscope image of a captured HEK cell. Highlighted in red,
the cell membrane is seen to protrude a distance of about 50 μm into the patching capillary shortly after being captured. (e) A single-use injection-molded device used for the
experiments. (f) Illustration of the setup used for the recordings. The polymer device is connected to two intracellular solution reservoirs and then to the pressure controller.
Ag/AgCl electrodes are connected to the head stage of the amplifier. Syringes are used to transport cells by convective flow from the inlet to the patch zone and to perfuse
lidocaine through one of the lateral apertures, respectively. (g) Schematic of the patch clamping recording: a cell trapped to a lateral aperture. Electrodes are located across
the orifice.
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and the polymer along the whole length of the patching cap-
illary and not only in the proximity of the orifice.
Our customized polymer chip, 50 mm in diameter and
2 mm in thickness, contained 12 Luer fittings39 used to inter-
face the microfluidic network. A single-use injection-molded
device is shown in Fig. 1e. Prior to experiments, the device
was primed with the electrolyte solutions. First, the capillary
was filled with an intracellular solution, and then, the cell
carrier channel was filled with an extracellular solution. The
recording channel was connected to an external pressure con-
troller, and reservoirs with the intracellular solution were
employed to prevent the formation of air bubbles when
applying suction. Ag/AgCl electrodes positioned across the
recording channel and connected to the amplifier ensured
electrical connection, as shown in Fig. 1f–g.
Cells were introduced into the inlet port and transported
by the convective flow induced by a syringe. Before trapping
one of the cells, a slight positive pressure was applied to the
patching channel to prevent contamination of the aperture.
Conveniently, one of the unused patching capillaries could
be used for perfusion of lidocaine by using a syringe
connected to the corresponding Luer port. During perfusion,
the estimated average flow velocity in the carrier channel was
approximately 1 mm s−1, and the average flow rate in the per-
fusion channel was estimated to be about 20% higher than
the flow rate in the carrier channel. The lateral flow was
applied for less than 10 seconds. A COMSOL® simulation,
shown in Fig. 2, supports the premise that 100% of the lido-
caine in solution was successfully delivered to the cell. The
simulation considered a worst case scenario of lidocaine
diffusion when a high lidocaine concentration of 1 mM
was perfused.
As previously reported,37 injection molding enables high
replication accuracy of micro- and nano-features. Fig. 3a–c
shows SEM micrographs of the orifice formed at the junc-
tion between the patching channel and the carrier channel
of a polymer device after the three main steps of the fabri-
cation process: etching, electroplating and molding. The
uniformity of the patching channels was confirmed for sev-
eral devices by the narrow range of chip resistances; the
resistances were measured across the 45 μm long patching
capillaries with the presence of only the electrolyte
solutions. This was 9.4 ± 1.1 MΩ (mean ± standard devia-
tion, n = 33) for type A devices and 10.5 ± 0.7 MΩ (n = 14)
for type B devices. The devices with semicircular profile
(type B) had a slightly larger chip resistance as expected
from their smaller cross-sectional area. Both devices showed
comparable resistance variation. Since the chip resistance is
mainly a function of the capillary geometry, its variation is
a good indication of variations in channel geometry.40 The
chip resistances are comparable to those reported by
Ionescu-Zanetti17 and Chen;38 however, the variation is sig-
nificantly smaller, indicating a better reproducibility of the
present method. However, the chip resistance is signifi-
cantly higher than the typical 2–4 MΩ access resistance
reported for planar patch clamping devices where the holes
are tapered on the back side.41 In addition, the parasitic
chip capacitance, that ideally should be as low as possible,
was monitored. This was 11.5 ± 0.5 pF for both devices A
and B. This capacitance was presumably dominated by the
parasitic capacitance of external wiring, as a much lower
estimated capacitance of about 10 fF can be obtained for
the chip itself by employing a simple model of a pair of
parallel wires, being effectively 150 μm long segments of
the 50 μm deep micro-channels, separated by a gap of 100 μm
(the length of the Y-shaped patching channel), and the dielec-
tric constant of TOPAS (εr = 2.35). For comparison, the chip
capacitances for the measurement plates for the QPatch™ are
55 ± 5 pF.
In order to test the devices, whole-cell recordings were
performed with human embryonic kidney (HEK) cells. Of
47 cells captured, 19 cells (40% of the total) allowed for
whole-cell access with seal resistance of at least 100 MΩ, and
of those, 7 (15%) were gigaseals. A success rate of 15% is thus
attributed to our experiments. The rest of the cells showed
either no whole-cell achievement or seal resistance below
100 MΩ. More precisely, tests were carried out on devices both
having patching capillaries with rectangular (type A, n = 33)
and semicircular (type B, n = 14) profiles. As shown in Table 1,
both device types showed very similar sealing capability and
ability to achieve the whole-cell configuration in a range of
seal resistances. Both profiles also have similar gigaseal fre-
quencies. The exact confidence interval for gigaseal frequency
was calculated using the Clopper–Pearson method42 and is
given at a confidence level of 90%. The confidence intervals
for gigaseal frequency were also comparable for the two pro-
files. During cell experiments, it was noted that high-
resistance seals could only be achieved on longer channels,
and shorter channels were also tested with cells, but they all
failed to deliver quality seals (data not reported). Importantly,
for the 45 μm long channels, each cell showing a seal resis-
tance above 250 MΩ also allowed for whole-cell recordings. It
was observed that tight seals appeared gradually after the
whole-cell configuration was established, eventually reaching
gigaseal during a period of 10–20 minutes. Achievement of
the whole-cell configuration was verified by activation of
sodium currents through a depolarization of the cell mem-
brane. Seals had an average lifetime of 30 minutes.
Fig. 2 Lidocaine (1 mM) delivery to the cell being patched, simulated in
COMSOL
®
. A lateral flow (in red) perfused into the flow in the carrier channel (in
blue). The simulation accounted for lidocaine diffusion in the extracellular solution. A
sectional view across the channel shows how the concentration corresponds to
100% in the proximity of the cell.
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Furthermore, it was also observed that whole-cell configura-
tion with rupture of the patched cell membrane was obtained
spontaneously upon cell capture without an intermediate
cell-attached state, where electrical access to the interior of
the cell goes through the patched piece of cell membrane
inside the pipette in traditional patch clamping experiments.
This seems to differ from other systems, both those using tra-
ditional pipettes and planar chips, where a drop in resistance
when breaking the cell membrane is normally observed.
In the literature, numerous discussions regarding the
importance of various device parameters for high-quality seal
formation exist, such as the aperture diameter,43 length of
membrane protrusion into the microhole,44 smooth edges of
the microholes,45 and hydrophilicity of the substrate.43 Addi-
tionally, these evaluations were done with different substrate
materials and capturing geometries and none with thermo-
plastic polymers. Although the proposed technology allows
for a valid device trade-off strategy based on shorter patching
channels having lower seal and series resistance, but relying
more on leak subtraction (see ESI†), our experiments indicate
that long and smooth patching channels and apertures of
approximately 4 μm2 with clean and smooth orifice edges
allow for good seal quality. Furthermore, these parameters
contribute to an increase in total contact area between the cell
membrane and the polymer surface, and therefore, the effec-
tive contact area seems to be the most critical prerequisite to
look at. To support this hypothesis, the topography of the ori-
fices and the inside of the patching capillaries were thor-
oughly characterized by atomic force microscopy (AFM). AFM
data from channels with rectangular and semicircular profiles
are compared in Table 2 and discussed here. The profiles
across the patching channels revealed the presence of scal-
lops with an average periodicity of approximately 180 nm for
type A profile chips with scallops generated by the Bosch-type
reactive ion etching process employed for master mold forma-
tion.46 The amplitude and periodicity of the scallops defines
the waviness of the surface and dominates the calculated
roughness value. To overcome the dominating effect of the
scallops and evaluate the surface roughness Rq between the
scallops, images were filtered using a cutoff wavelength
shorter than the average periodicity between the scallops.
After filtering, the surface roughness of the sidewalls of the
Fig. 3 (a–c) SEM micrographs of the patching orifice after the main three steps of the fabrication process for type A devices: silicon master, nickel insert, and replicated
polymer part (from left to right). (d) 3D AFM image of the patching orifice (type A). (e) 3D AFM image of the sidewall of the patching capillary (type A). (f) 3D AFM image of
the semicircular patching orifice (type B). (g) 3D AFM image of the sidewall of the semicircular patching capillary (type B).
Table 1 The table shows the number of cells that were successfully sealed and perforated into whole-cell configuration. The numbers include the cells with
higher seals. The number of cells that were successfully perforated into whole-cell configuration is shown in parentheses. The exact confidence interval for the
gigaseal frequency was calculated at a confidence level of 90%
Device
Total of cells
tested
R < 100
MΩ
R > 100
MΩ
R > 250
MΩ
R > 1000
MΩ
Gigaseal
frequency
Confidence interval for
gigaseal
Rectangular
profile (A)
33 14 (9) 20 (13) 8 (8) 5 (5) 15% 6%–29%
Semicircular
profile (B)
14 6 (4) 8 (6) 3 (3) 2 (2) 14% 3%–38%
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rectangular and semicircular channels are comparable and in
the range of 1 to 2 nm. Therefore, the surface roughness Rq
of the sidewall for both samples seems to be determined pri-
marily by the smoothening steps that were the same for both.
In general, the inside of the patching channel, including the
bottom of the channel and the foil, exhibits very low surface
roughness Rq of 1 to 2 nm, and it is also here, between the
cell membrane and the polymer, that the seal is assumed to
form. These findings suggest that the surface roughness
inside the patching channel is a second prerequisite for good
seal formation. In contrast, the waviness originating from the
scallops does not seem to influence the seal quality. The cell
membrane, which has a thickness of only 5–10 nm, is likely to
conform to the shape of the surface waviness, which has a
periodicity much larger than the thickness of the cell mem-
brane. This effect has been studied before for pipette tip
roughness.47 Hence, one can hypothesize that low surface
roughness in addition to the patch channel length increases
the effective contact area between the cell membrane and the
polymer surface and, thus, facilitates the formation of tight
seals. The shape of the cross section, either rectangular
or semicircular, did not influence the capability of seal
formation.
Electrophysiological cell experiments were designed to
record activation and inactivation currents in whole-cell volt-
age clamp mode from voltage-gated sodium ion channels
Nav1.7. Sodium channels play an essential role for the
generation of action potentials in excitable cells, and they
have a key role in pain perception.48 In order to benchmark
the performance of the polymer devices, electrophysiology
data taken using the devices were compared with data taken
using the commercially available QPatch™ system. The cells,
the electrolyte solutions and the compounds used for the
QPatch™ recordings and for the polymer chip recordings
were exactly the same. Raw data were collected and subse-
quently leak subtracted in order to compensate for the
capacitance; Fig. 4a shows an example of a family of sodium
activation currents. A +10 mV square pulse of 10 ms from
−90 mV prior to depolarization was used to calculate the leak
current that was subtracted from the recorded data.49 A
description of leak subtraction is provided in the ESI.†
Automated P/n leak subtraction50 was employed in the
QPatch™ system. Activation currents were obtained after the
start of depolarization pulses from −90 mV to 70 mV, while
the holding potential was kept at −90 mV for all the experi-
ments. Steady-state inactivation currents were investigated at
+10 mV after conditioning potentials ranging from −90 mV to
70 mV were applied for 1000 ms. The resulting current ampli-
tude represents the portion of sodium channels in the acti-
vated and inactivated states, respectively. For the polymer
devices, the activation threshold was found to be between
−50 and −40 mV, and the maximal current amplitude was
obtained for voltages between −30 and −20 mV. At positive
potentials, the current amplitude gradually decreased as the
electrochemical driving force disappeared. The IV curves
show good agreement with those obtained using the
QPatch™ system. However, IV curves from the polymer device
had a tendency to shift towards more negative potentials.
Fig. 4b shows two representative IV curves for both systems.
The inactivation graph in Fig. 4d shows the gradual transi-
tion from a state where the sodium channels were predomi-
nantly closed to a state where they were predominantly
inactivated, above −50 mV for the polymer devices. The
cutoff at −90 mV does not show at which potential the
transition starts but is presumed to be at about −100 mV.
As mentioned for the activation currents, the IV rela-
tionships obtained for the polymer devices, when com-
pared to IVs from the QPatch™ system, had the tendency
to shift towards more negative potentials. This shift was
attributed to voltage drops across the higher access resis-
tance of the polymer device, which was not compensated
for, while series resistance compensation was employed
for the QPatch™ recordings. Series resistance compen-
sation for the used HEKA amplifier is tailored to the
electrical properties of glass pipettes. Due to their diffe-
rent impedance properties, we did not expect the usual
dynamic series resistance compensation to work properly
for the polymer devices reported on here. Hence, in order
to avoid amplifier oscillations, we did not employ the
series resistance compensation for the polymer chip. An
additional explanation for the shape of the IV relation-
ship could also be rooted in the expected difference in
Table 2 The root mean square deviation Rq of the assessed profiles for injection-molded polymer parts inside the patching capillaries for the two geometries.
The image side length was 1.3 μm. The standard uncertainty is given at a confidence level of 68%. All measurements were carried out using a MultiMode 8 atomic
force microscope from Bruker in intermittent contact mode using single crystal silicon cantilevers with spring constants of approximately 40 mN and radius of cur-
vature of 5 nm to 10 nm
Device
Rq (nm) Rq (nm) Rq (nm)
Bottom of patching capillary Sidewall patching capillary Foil
Rectangular profile 2.0 ± 0.3 6.5 ± 1.3a 1.2 ± 0.2
(2.4 ± 0.4)b
Semicircular profile 0.7 ± 0.2 1.0 ± 0.2a 1.2 ± 0.2
(0.8 ± 0.1)b
a The image was line-wise corrected by a second-order least mean squares fit in order to remove the (semicircular) shape of the profile. b The
surface roughness Rq was calculated from an image after it was filtered so that only shortwave profile components with a cutoff wavelength of
λ = 0.18 μm are included. The filtering was done to avoid the influence of the Bosch process-induced scallops on the calculated surface rough-
ness (only relevant for profile A devices).
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Fig. 5 (a) Protocol used for determining the concentration–response relationship of lidocaine inhibition on Nav1.7 channels consisting of two depolarizations to 0 mV from a
holding potential of −100 mV with an interval of 15 ms. (b) Raw current response from a recording on the polymer device before lidocaine application. The amplitude of peak
2 is about 80% of the amplitude of peak 1. (c) Raw current response for peak 1 and peak 2 before (black) and after (red) 100 μM lidocaine was applied to the cell.
(d) Activation currents for Nav1.7 channels for determining the lidocaine inhibition on Nav1.7 channels. The graph shows values of the current amplitudes of peaks 1 and 2
before and after 100 μM lidocaine was applied to the cell. Peak 1 is not affected, and peak 2 is reduced by 50%. (e) Concentration–response relationships of lidocaine
inhibition on Nav1.7 channels. Data were fitted with a Hill-type equation. IC50 was 119 ±11 μM (Hill coefficient n = 1) for the polymer device and 152 ±12 μM (Hill coefficient
n = 0.9) for the QPatch
™
.
Fig. 4 (a) A family of Na
+
activation currents in response to depolarization pulses from −90 mV to 70 mV, measured on the polymer device. The protocol used for
determining both activation and inactivation is also shown. The membrane potential was held at a holding potential of −90 mV, subsequently shifted to potentials ranging
from −90 to 70 mV for 1000 ms, and finally to 10 mV. To the left, the raw current responses are shown, and to the right, the data after leak subtraction. (b) The resulting
IV relationship for peak Na
+
channel currents. The activation threshold was −50 mV, and the maximal current amplitude was obtained at −30 mV for the polymer device.
The threshold was −30 mV with a maximum at −10 mV for the QPatch™. (c) A family of Na+ inactivation currents from the same recording upon the step to 10 mV. To the
left, the raw current responses are shown, and to the right, the data after leak subtraction. (d) The inactivation graph for the Na
+
channel. At potentials more negative than
−80 mV, the channels were predominantly closed, whereas at potentials above −30 mV, they were predominantly inactivated for the QPatch™. For the polymer device, the
channels were predominantly inactivated at potentials above −50 mV.
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the mechanical state of the cell membrane in the poly-
mer chip and the QPatch™. Such effects are known to
cause shifting of the IV relationships.51 As we shall see
in the following, this difference did not influence the
pharmacological studies.
Dose–response experiments were carried out to further
benchmark the polymer device with a pharmacological appli-
cation. Lidocaine inhibition of whole-cell sodium currents
was explored in voltage-clamped mode by application of lido-
caine concentrations ranging from 30 μM to 1 mM. The
ability of lidocaine to bind to sodium channels is state
dependent, as lidocaine binds to the sodium channel in the
inactivated state only.52 To explore state dependency, the cell
was depolarized twice at 0 mV for 100 ms and 20 ms, respec-
tively, from a holding potential of −100 mV with a temporal
separation of 15 ms, see Fig. 5a. Depolarization was repeated
every 5 seconds. Lidocaine response was studied at the start
of the second pulse after the resting interval, during which
only a portion of the sodium channels was able to recover
from inactivation. Fig. 5b shows a typical recording in the
absence of compound where the activation peak 2 was about
80% of the size of the activation peak 1, used as a reference.
When lidocaine was applied, reference peak 1 exhibited a
current that was almost unchanged, while peak 2 was sub-
stantially reduced. Fig. 5c shows activation currents from the
same cell before and after 100 μM lidocaine was delivered to
the cell. The current–time relationship for the peak sodium
currents recorded in response to the first (empty circle) and
the second (full circle) depolarization is shown in Fig. 5d.
Inhibition is plotted against lidocaine concentration in
Fig. 5e. The amplitudes of sodium currents immediately prior
to lidocaine application were set to 100%. Complete inhibi-
tion was observed at 1 mM lidocaine, while the inhibition
was only 20% at 30 μM lidocaine which was also the lowest
concentration applied. From Fig. 5d, it can be observed that
the inhibition produced by lidocaine was reversible within
60 seconds after its perfusion was stopped. For the polymer
device, the half-blocking concentration IC50 was 119 ± 11 μM.
This value is in excellent agreement with the IC50 of 152 ±
11 μM found with the QPatch™. The Hill coefficients were
also very similar for the two systems.
Conclusions
We have demonstrated electrophysiological recordings on an
injection-molded polymer device platform for the first time.
The results demonstrate that polymer APC devices can pro-
vide whole-cell current responses from voltage-gated sodium
channels and permit accurate analysis of drug potency for
state-dependent inhibitors such as for the local anesthetic
lidocaine. Moreover, the devices exhibit excellent data quality
when benchmarked against the commercially available
QPatch™ system. Formation of gigaseals (15% of the total
cells) between the polymer surfaces and the cell membranes
was achieved by making patching capillaries that allowed for
a large sealing area. The length of the patching channel
together with the low surface roughness on the inside of the
patching capillaries were identified as the most important
parameters for good seal formation. We attribute this obser-
vation to indicate that a large effective sealing area between
the cell membrane and the polymer surface is required to
obtain tight seals. Most likely, the exceptionally large sealing
area required for the polymer patching channels when com-
pared to silica-based channels is necessary to assist sealing
due to slow van der Waals type interactions between the rela-
tively low-energy polymer surface and the cell membrane.
However, the long patching channels pose an engineering
challenge for proper series resistance compensation when
compared to traditional glass pipette recordings. Finally, we
have successfully combined the simplicity of lateral cornered
apertures with the use of injection molding to demonstrate
the most cost-effective production and materials platform for
APC systems to date. The technological readiness level of the
reported material and production platform is high, while the
specific design of the intra- and extracellular channels
(Fig. 1a) is only aimed at prototyping. Thus, the Y-shaped
patching channel constitutes the only essential feature of our
microfluidic design, and channels for extra- and intracellular
electrolyte solutions could be designed differently for a much
smaller unit footprint. For maintaining exactly the same
functionality per functional chip unit, six inlet/outlet wells
would still be required. However, if we allow shared cell and
compound inlets, one chip unit will require only four ports.
Acknowledgements
We gratefully acknowledge financial support from the Danish
Advanced Technology Foundation through the Advanced
Technology Project PILOC (grant no. 061-2010-1) and from
the Danish Council for Strategic Research through the Strate-
gic Research Center PolyNano (grant no. 10-092322/DSF).
References
1 E. Neher and B. Sakmann, Nature, 1976, 260, 799–802.
2 B. Hille, Ion Channels of Excitable Membranes, Sinauer
Associates, Inc., Sunderland, MA, USA, 2001.
3 F. Lehmann-Horn and K. Jurkat-Rott, Physiol. Rev., 1999, 79,
1317–1372.
4 M. Ackerman and D. Clapham, N. Engl. J. Med., 1997, 336,
1575–1586.
5 F. Ashcroft, Nature, 2006, 440, 440–447.
6 J. P. Overington, B. Al-Lazikani and A. L. Hopkins, Nat. Rev.
Drug Discovery, 2006, 5, 993–996.
7 A. Wickenden, B. Priest and G. Erdemli, Future Med. Chem.,
2012, 4, 661–679.
8 J. Xu, X. Wang, B. Ensign, M. Li, L. Wu, A. Guia and J. Xu,
Drug Discovery Today, 2001, 6, 1278–1287.
9 W. Zheng, R. Spencer and L. Kiss, Assay Drug Dev. Technol.,
2004, 2, 543–552.
Lab on a ChipPaper
4792 | Lab Chip, 2013, 13, 4784–4793 This journal is © The Royal Society of Chemistry 2013
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
Se
pt
em
be
r 2
01
3.
 D
ow
nl
oa
de
d 
on
 1
9/
11
/2
01
4 
10
:0
8:
55
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
10 J. Xu, A. Guia, D. Rothwarf, M. Huang, K. Sithiphong,
J. Ouang, G. Tao, X. Wang and L. Wu, Assay Drug Dev.
Technol., 2003, 1, 675–684.
11 J. Dunlop, M. Bowlby, R. Peri, D. Vasilyev and R. Arias,
Nat. Rev. Drug Discovery, 2008, 7, 358–368.
12 C. Wood, C. Williams and G. Waldron, Drug Discovery
Today, 2004, 9, 434–441.
13 C. Farre, M. George, A. Bruggemann and N. Fertig,
Drug Discovery Today: Technol., 2008, 5, e23–e28.
14 C. Farre and N. Fertig, Expert Opin. Drug Discovery, 2012, 7,
515–524.
15 N. Fertig, R. Blick and J. Behrends, Biophys. J., 2002, 82,
3056–3062.
16 M. Asmild, N. Oswald, K. Krzywkowski, S. Friis, R. Jacobsen,
D. Reuter, R. Taboryski, J. Kutchinsky, R. Vestergaard,
R. Schroder, C. Sorensen, M. Bech, M. Korsgaard and
N. Willumsen, Recept. Channels, 2003, 9, 49–58.
17 C. Ionescu-Zanetti, R. Shaw, J. Seo, Y. Jan, L. Jan and L. Lee,
Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 9112–9117.
18 D. Martinez, C. Py, M. W. Denhoff, M. Martina, R. Monette,
T. Comas, C. Luk, N. Syed and G. Mealing, Biomed.
Microdevices, 2010, 12, 977–985.
19 A. Stett, V. Bucher, C. Burkhardt, U. Weber and W. Nisch,
Med. Biol. Eng. Comput., 2003, 41, 233–240.
20 K. Klemic, J. Klemic, M. Reed and F. Sigworth, Biosens.
Bioelectron., 2002, 17, 597–604.
21 X. Li, K. Klemic, M. Reed and F. Sigworth, Nano Lett.,
2006, 6, 815–819.
22 B. Xu, Z. Liu, Y. Lee, A. Mak and M. Yang, Sens. Actuators, A,
2011, 166, 219–225.
23 T. M. Suchyna, V. S. Markin and F. Sachs, Biophys. J.,
2009, 97, 738–747.
24 C. Miller, Biophys. J., 2009, 97, 687–687.
25 A. Priel, Z. Gil, V. T. Moy, K. L. Magleby and S. D. Silberberg,
Biophys. J., 2007, 92, 3893–3900.
26 J. Israelachvili and H. Wennerstrom, Nature, 1996, 379,
219–225.
27 M. Schulz, A. Olubummo and W. H. Binder, Soft Matter,
2012, 8, 4849–4864.
28 V. Tandon, S. K. Bhagavatula and B. J. Kirby, Electrophoresis,
2009, 30, 2656–2667.
29 V. Tandon, S. K. Bhagavatula, W. C. Nelson and B. J. Kirby,
Electrophoresis, 2008, 29, 1092–1101.
30 V. Tandon and B. J. Kirby, Electrophoresis, 2008, 29,
1102–1114.
31 J. Seo, C. Ionescu-Zanetti, J. Diamond, R. Lal and L. Lee,
Appl. Phys. Lett., 2004, 84, 1973–1975.
32 A. P. Golden, N. Li, Q. Chen, T. Lee, T. Nevill, X. Cao,
J. Johnson, G. Erdemli, C. Ionescu-Zanetti, L. Urban and
M. Holmqvist, Assay Drug Dev. Technol., 2011, 9, 608–619.
33 B. Fermini, Top. Med. Chem., 2008, 3, 1–25.
34 E. Berthier, E. W. K. Young and D. Beebe, Lab Chip,
2012, 12, 1224–1237.
35 M. Matteucci, T. L. Christiansen, S. Tanzi, P. F. Ostergaard,
S. T. Larsen and R. Taboryski, Microelectron. Eng., 2013, 111,
294–298.
36 H. Becker, Lab Chip, 2009, 9, 2759–2762.
37 S. Tanzi, P. F. Ostergaard, M. Matteucci, T. L. Christiansen,
J. Cech, R. Marie and R. Taboryski, J. Micromech. Microeng.,
2012, 22, 115008.
38 C. Chen and A. Folch, Lab Chip, 2006, 6, 1338–1345.
39 K. O. Andresen, M. Hansen, M. Matschuk, S. T. Jepsen,
H. S. Sorensen, P. Utko, D. Selmeczi, T. S. Hansen,
N. B. Larsen, N. Rozlosnik and R. Taboryski, J. Micromech.
Microeng., 2010, 20, 055010.
40 W. Ong, K. Tang, A. Agarwal, R. Nagarajan, L. Luo and
L. Yobas, Lab Chip, 2007, 7, 1357–1366.
41 J. Kutchinsky, S. Friis, M. Asmild, R. Taboryski,
S. Pedersen, R. Vestergaard, R. Jacobsen, K. Krzywkowski,
R. Schroder, T. Ljungstrom, N. Helix, C. Sorensen, M. Bech
and N. Willumsen, Assay Drug Dev. Technol., 2003, 1,
685–693.
42 C. J. Clopper and E. S. Pearson, Biometrika, 1934, 26,
404–413.
43 K. Klemic, J. Klemic, M. Reed and F. Sigworth, Biosens.
Bioelectron., 2002, 17, 597–604.
44 T. Sordel, F. Kermarrec, Y. Sinquin, I. Fonteille, M. Labeau,
F. Sauter-Starace, C. Pudda, F. d. Crecy, F. Chatelain,
M. D. Waard, C. Arnoult and N. Picollet-D'hahan,
Biomaterials, 2010, 31, 7398–7410.
45 F. Sigworth and K. Klemic, Biophys. J., 2002, 82, 2831–2832.
46 R. Abdolvand and F. Ayazi, Sens. Actuators, A, 2008, 144,
109–116.
47 M. Malboubi, Y. Gu and K. Jiang, Microelectron. Eng.,
2010, 87, 778–781.
48 F. Yu and W. Catterall, Genome Biol., 2003, 4, 207.
49 J. Dempster, in, ed. Anonymous, Academic Press, London,
2001, pp. 172–225.
50 F. Bezanilla and C. M. Armstrong, J. Gen. Physiol., 1977, 70,
549–566.
51 D. Schmidt and R. MacKinnon, Proc. Natl. Acad. Sci. U. S. A.,
2008, 105, 19276–19281, DOI: 10.1073/pnas.0810187105.
52 B. Bean, C. Cohen and R. Tsien, J. Gen. Physiol., 1983, 81,
613–642.
Lab on a Chip Paper
Lab Chip, 2013, 13, 4784–4793 | 4793This journal is © The Royal Society of Chemistry 2013
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 2
3 
Se
pt
em
be
r 2
01
3.
 D
ow
nl
oa
de
d 
on
 1
9/
11
/2
01
4 
10
:0
8:
55
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n 
3.
0 
U
np
or
te
d 
Li
ce
nc
e.
View Article Online
